Three Ways to Slow Down Type 2 Diabetes-Related Brain Aging

Health & Lifestyle
215

Listen to article (english)

Translate to Spanish or other 102 languages!

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes
Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes

Medical News Today

- Advertisement -

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Researchers have also discovered evidence of diabetes leading to faster brain aging, which could increase the risk of Alzheimer’s. But is there a way to prevent this, and how so? In this podcast, we discuss lifestyle interventions that could help slow diabetes-related cognitive decline.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/3-lifestyle-changes-slow-down-type-2-diabetes-related-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#1

- Advertisement -

Information Source:  https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
EPA is Requiring the Removal of Lead Pipes in the U.S. 
Next article
Americans are Meeting Minimum Needs for Essential Amino Acids

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -